{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-078695","form_type":"8-K","ticker":"HLYK","cik":"0001680139","company_name":"HealthLynked Corp","filed_at":"2026-07-16T20:02:20+00:00","discovered_at":"2026-07-16T20:03:00.442800+00:00","generated_at":"2026-07-16T20:03:07.610555+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"HealthLynked appoints George O'Leary as Interim CFO; COO position eliminated","bullets":["George O'Leary appointed part-time Interim CFO effective July 13, 2026; compensation $15,000/month.","O'Leary receives 35,000 stock options at $3.50/share, vesting only upon Nasdaq listing approval.","Jeremy Daniel stepped down as CFO, transitions to corporate accounting role; no disagreement.","COO Duncan McGillivray to depart July 24, 2026; position eliminated; becomes Senior Strategic Advisor.","O'Leary's primary goal is to lead Nasdaq uplisting and assist with planned $7.5M institutional financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-078695","json":"https://secwatch.observer/filing/0001213900-26-078695.json","markdown":"https://secwatch.observer/filing/0001213900-26-078695.md","text":"https://secwatch.observer/filing/0001213900-26-078695.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680139/000121390026078695/0001213900-26-078695-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680139/000121390026078695/ea0298212-8k_health.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T20:03:07.610555+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3fbffd714f","claim":"Jeremy Daniel departed as Chief Financial Officer at HealthLynked Corp.","evidence_excerpt":"Effective July 13, 2026, Jeremy Daniel ceased serving as Chief Financial Officer and transitioned to a corporate accounting role with the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680139/000121390026078695/0001213900-26-078695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"ceased serving"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"86281214a2","claim":"George O'Leary was appointed as Interim Chief Financial Officer at HealthLynked Corp.","evidence_excerpt":"Effective July 13, 2026, HealthLynked Corp., a Nevada corporation (the “ Company ”), appointed George O’Leary, age 63, as its part-time Interim Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680139/000121390026078695/0001213900-26-078695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Chief Financial Officer"}],"fact_type":"executive_change"},{"claim_id":"a82b28e9ad","claim":"Duncan McGillivray departed as Chief Operating Officer at HealthLynked Corp.","evidence_excerpt":"Accordingly, Duncan McGillivray will cease serving as the Company’s Chief Operating Officer effective July 24, 2026.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1680139/000121390026078695/0001213900-26-078695-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"will cease serving"},{"label":"Role","value":"Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}